Literature DB >> 2648394

The ras and myc oncogenes cooperate in tumor induction in many tissues when introduced into midgestation mouse embryos by retroviral vectors.

S J Compere1, P Baldacci, A H Sharpe, T Thompson, H Land, R Jaenisch.   

Abstract

Midgestation embryos were infected with replication-defective retroviral vectors that either transduced the myc oncogene, the ras oncogene, or both oncogenes simultaneously. The myc virus induced tumors in diverse organs at a very low frequency and with a long latency period, while approximately 20% of the mice derived from embryos infected with the ras virus developed tumors in the skin with a latency of 4-8 weeks. In contrast, infection of embryos with the ras/myc double oncogene virus resulted in 27% of the animals developing rapidly growing and malignant tumors in a great variety of tissues after a median latency period of 2-3 weeks. All tumors were of monoclonal origin, as shown by Southern analysis using the provirus as a molecular marker. Our results are consistent with the hypothesis that the ras and myc oncogenes cooperate in transforming cells, but that additional alterations are necessary for realization of the fully malignant phenotype. Our observations also suggest that a much wider range of cell types become targets for malignant transformation when the embryos are exposed to the myc and the ras oncogenes simultaneously than when exposed to the same oncogenes separately. Infection of mouse embryos with vectors carrying different oncogenes or oncogene combinations may be an efficient and rapid method for evaluating the spectrum of cell types at risk for malignant conversion following mutation of a protooncogene to a transforming gene.

Entities:  

Mesh:

Year:  1989        PMID: 2648394      PMCID: PMC286884          DOI: 10.1073/pnas.86.7.2224

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector.

Authors:  R D Cone; A Weber-Benarous; D Baorto; R C Mulligan
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

3.  Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts.

Authors:  H Land; A C Chen; J P Morgenstern; L F Parada; R A Weinberg
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

4.  Retroviruses and mouse embryos: a rapid model for neurovirulence and transplacental antiviral therapy.

Authors:  A H Sharpe; R Jaenisch; R M Ruprecht
Journal:  Science       Date:  1987-06-26       Impact factor: 47.728

5.  Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.

Authors:  E Sinn; W Muller; P Pattengale; I Tepler; R Wallace; P Leder
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

6.  Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice.

Authors:  C J Quaife; C A Pinkert; D M Ornitz; R D Palmiter; R L Brinster
Journal:  Cell       Date:  1987-03-27       Impact factor: 41.582

7.  Clonal analysis of human colorectal tumors.

Authors:  E R Fearon; S R Hamilton; B Vogelstein
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

8.  Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice.

Authors:  A C Andres; C A Schönenberger; B Groner; L Hennighausen; M LeMeur; P Gerlinger
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

9.  Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.

Authors:  Y Suda; S Aizawa; S Hirai; T Inoue; Y Furuta; M Suzuki; S Hirohashi; Y Ikawa
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

10.  c-myc and c-fos expression in differentiating mouse primary keratinocytes.

Authors:  G P Dotto; M Z Gilman; M Maruyama; R A Weinberg
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  10 in total

1.  Exposure of organ cultures from human tracheal epithelium to chemical carcinogens and subsequent long-term co-cultivation with autologous isotopic fibroblasts.

Authors:  I Haas; P Koldovsky; U Ganzer
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

Review 2.  The MYC oncogene is a global regulator of the immune response.

Authors:  Stephanie C Casey; Virginie Baylot; Dean W Felsher
Journal:  Blood       Date:  2018-03-07       Impact factor: 22.113

Review 3.  Making better transgenic models: conditional, temporal, and spatial approaches.

Authors:  Sika Ristevski
Journal:  Mol Biotechnol       Date:  2005-02       Impact factor: 2.695

4.  Hormonal regulation of the gene for the type C ecotropic retrovirus receptor in rat liver cells.

Authors:  J Y Wu; D Robinson; H J Kung; M Hatzoglou
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose.

Authors:  H Radner; Y el-Shabrawi; R H Eibl; O Brüstle; L Kenner; P Kleihues; O D Wiestler
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 6.  MYC activation is a hallmark of cancer initiation and maintenance.

Authors:  Meital Gabay; Yulin Li; Dean W Felsher
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

Review 7.  The H-2KbtsA58 transgenic mouse: a new tool for the rapid generation of novel cell lines.

Authors:  M Noble; A K Groves; P Ataliotis; Z Ikram; P S Jat
Journal:  Transgenic Res       Date:  1995-07       Impact factor: 2.788

Review 8.  Inactivation of MYC reverses tumorigenesis.

Authors:  Y Li; S C Casey; D W Felsher
Journal:  J Intern Med       Date:  2014-07       Impact factor: 8.989

9.  Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing.

Authors:  J H Song; N An; S Chatterjee; E Kistner-Griffin; S Mahajan; S Mehrotra; A S Kraft
Journal:  Oncogene       Date:  2014-09-22       Impact factor: 9.867

10.  Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.

Authors:  Roderik M Kortlever; Nicole M Sodir; Catherine H Wilson; Deborah L Burkhart; Luca Pellegrinet; Lamorna Brown Swigart; Trevor D Littlewood; Gerard I Evan
Journal:  Cell       Date:  2017-11-30       Impact factor: 41.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.